Preimplantation Genetic Testing Market Size, Share, Trends & Forecast

The Preimplantation Genetic Testing Market is expanding as assisted reproductive technology becomes increasingly sophisticated and prospective parents seek additional information about embryos before transfer. Preimplantation genetic testing is performed as part of an IVF process and can be used to assess embryos for chromosomal abnormalities, specific genetic disorders, and structural chromosomal rearrangements. Recent market research estimates the global market at approximately USD 927 million in 2025 and projects it to reach USD 2.37 billion by 2033, representing a CAGR of 13.0%.

PGT includes several categories, including PGT-A for aneuploidy, PGT-M for monogenic conditions, and PGT-SR for structural chromosomal rearrangements. PGT-M can be particularly valuable for families with a known risk of transmitting a specific inherited disorder. The American Society for Reproductive Medicine notes that PGT-M can be used for many Mendelian conditions, although testing requires individualized laboratory preparation and genetic counseling.

Technological advances are supporting market development. Improvements in embryo biopsy techniques, DNA amplification, next-generation sequencing, and laboratory workflows have expanded the capabilities of genetic testing. Reagents and consumables represent an important part of the market, while PCR and sequencing-based technologies continue to support different testing applications.

Growing awareness of inherited diseases and increased use of carrier screening are also contributing to demand. As more couples learn about potential reproductive genetic risks, interest in testing options before embryo transfer can increase.

However, PGT remains a complex clinical process. Genetic counseling, laboratory accuracy, embryo availability, and the limitations of testing results are important considerations. The ASRM also emphasizes that PGT-A should not currently be viewed as a routine screening test for every IVF patient because its overall value varies by clinical context.

With continued advances in reproductive genetics and IVF technology, the Preimplantation Genetic Testing Market is expected to develop further, particularly as laboratories improve testing accuracy, workflow efficiency, and accessibility.

Strengthen your strategy with data-backed research insights:

Spain Peptide Anticoagulant Drugs Market Outlook

UK Clinical Data Analytics Market Analysis

China Oral Anticoagulants Market Distribution

Germany PEG 3500 Market Size

India Integrated Operating Room Management Systems Market Share